» Articles » PMID: 24576094

RBR E3 Ubiquitin Ligases: New Structures, New Insights, New Questions

Overview
Journal Biochem J
Specialty Biochemistry
Date 2014 Mar 1
PMID 24576094
Citations 149
Authors
Affiliations
Soon will be listed here.
Abstract

The RBR (RING-BetweenRING-RING) or TRIAD [two RING fingers and a DRIL (double RING finger linked)] E3 ubiquitin ligases comprise a group of 12 complex multidomain enzymes. This unique family of E3 ligases includes parkin, whose dysfunction is linked to the pathogenesis of early-onset Parkinson's disease, and HOIP (HOIL-1-interacting protein) and HOIL-1 (haem-oxidized IRP2 ubiquitin ligase 1), members of the LUBAC (linear ubiquitin chain assembly complex). The RBR E3 ligases share common features with both the larger RING and HECT (homologous with E6-associated protein C-terminus) E3 ligase families, directly catalysing ubiquitin transfer from an intrinsic catalytic cysteine housed in the C-terminal domain, as well as recruiting thioester-bound E2 enzymes via a RING domain. Recent three-dimensional structures and biochemical findings of the RBRs have revealed novel protein domain folds not previously envisioned and some surprising modes of regulation that have raised many questions. This has required renaming two of the domains in the RBR E3 ligases to more accurately reflect their structures and functions: the C-terminal Rcat (required-for-catalysis) domain, essential for catalytic activity, and a central BRcat (benign-catalytic) domain that adopts the same fold as the Rcat, but lacks a catalytic cysteine residue and ubiquitination activity. The present review discusses how three-dimensional structures of RBR (RING1-BRcat-Rcat) E3 ligases have provided new insights into our understanding of the biochemical mechanisms of these important enzymes in ubiquitin biology.

Citing Articles

Perception of viral infections and initiation of antiviral defence in rice.

Huang Y, Yang J, Sun X, Li J, Cao X, Yao S Nature. 2025; .

PMID: 40074903 DOI: 10.1038/s41586-025-08706-8.


Ubiquitination Enzymes in Cancer, Cancer Immune Evasion, and Potential Therapeutic Opportunities.

Awan A, Osman M, Khan O Cells. 2025; 14(2).

PMID: 39851497 PMC: 11763706. DOI: 10.3390/cells14020069.


is Expressed on the Left Side of the Brain Vesicle in the Ascidian Larva.

Kim G Dev Reprod. 2025; 28(4):121-128.

PMID: 39845515 PMC: 11750163. DOI: 10.12717/DR.2024.28.4.121.


E2-Ub-R74G strategy reveals E2-specific ubiquitin conjugation profiles in live cells.

Shen S, Yin H Nat Chem Biol. 2025; .

PMID: 39762535 DOI: 10.1038/s41589-024-01809-9.


Androgen-targeted hsa_circ_0085121 encodes a novel protein and improves the development of prostate cancer through facilitating the activity of PI3K/Akt/mTOR pathway and enhancing AR-V7 alternative splicing.

Li J, Qiu H, Dong Q, Yu H, Piao C, Li Z Cell Death Dis. 2024; 15(11):848.

PMID: 39567496 PMC: 11579034. DOI: 10.1038/s41419-024-07246-9.


References
1.
Iguchi M, Kujuro Y, Okatsu K, Koyano F, Kosako H, Kimura M . Parkin-catalyzed ubiquitin-ester transfer is triggered by PINK1-dependent phosphorylation. J Biol Chem. 2013; 288(30):22019-32. PMC: 3724655. DOI: 10.1074/jbc.M113.467530. View

2.
Yin Q, Lin S, Lamothe B, Lu M, Lo Y, Hura G . E2 interaction and dimerization in the crystal structure of TRAF6. Nat Struct Mol Biol. 2009; 16(6):658-66. PMC: 2834951. DOI: 10.1038/nsmb.1605. View

3.
Stieglitz B, Rana R, Koliopoulos M, Morris-Davies A, Schaeffer V, Christodoulou E . Structural basis for ligase-specific conjugation of linear ubiquitin chains by HOIP. Nature. 2013; 503(7476):422-426. PMC: 3838313. DOI: 10.1038/nature12638. View

4.
Schlieker C, Weihofen W, Frijns E, Kattenhorn L, Gaudet R, Ploegh H . Structure of a herpesvirus-encoded cysteine protease reveals a unique class of deubiquitinating enzymes. Mol Cell. 2007; 25(5):677-87. PMC: 7110467. DOI: 10.1016/j.molcel.2007.01.033. View

5.
Cho P, Poulin F, Cho-Park Y, Cho-Park I, Chicoine J, Lasko P . A new paradigm for translational control: inhibition via 5'-3' mRNA tethering by Bicoid and the eIF4E cognate 4EHP. Cell. 2005; 121(3):411-23. DOI: 10.1016/j.cell.2005.02.024. View